Recent Events & Catalysts
Takeda Pharmaceutical Company Limited (TAK) — real, dated facts. Not a claim about what caused any single day's price move.
Committee Signals
Proprietary signals generated by the Innellis AI committee — score changes, rating shifts, and analyst disagreements.
No committee signals recorded yet.
News
Department Of Veterans Affairs Awards Takeda $5.6B Contract for Drugs And Biologicals Through 2031
Benzinga · 1d ago
Takeda's Pipeline Looks Encouraging, But Generic Erosion Is A Near-Term Concern
SeekingAlpha · 4d ago
Takeda nets first-in-class advantage on narcolepsy drug’s FDA go-ahead
Yahoo · 5d ago
Takeda approval ushers in new wave of sleep drugs
Yahoo · 5d ago
Takeda Achieves Major Milestone With Holistic Narcolepsy Drug Approval
Benzinga · 5d ago
Exelixis Inc (EXEL) (Q2 2026) Earnings Call Highlights: Strong Cabozantinib Growth Offsets NET ...
Yahoo · 5d ago
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 1
Yahoo · 5d ago
Takeda's ORZEYFUL Wins FDA Approval As First Orexin Therapy For Narcolepsy Type 1; U.S. Launch Planned Following DEA Scheduling
Benzinga · 6d ago
SEC Filings (90 days)
No 8-K filings in the last 90 days.
Earnings
No recent earnings data available.
Latest Analyst Action
No recent analyst actions available.